Joan Hooper Sells 355 Shares of Itron (NASDAQ:ITRI) Stock

Itron, Inc. (NASDAQ:ITRI) CFO Joan Hooper sold 355 shares of the company’s stock in a transaction dated Wednesday, May 20th. The stock was sold at an average price of $79.60, for a total transaction of $28,258.00. Following the transaction, the chief financial officer owned 117,920 shares in the company, valued at approximately $9,386,432. This trade represents a 0.30% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Itron Stock Up 1.4%

Shares of NASDAQ ITRI opened at $83.02 on Friday. The firm’s 50-day simple moving average is $88.45 and its 200 day simple moving average is $94.52. The company has a market cap of $3.68 billion, a price-to-earnings ratio of 13.24, a price-to-earnings-growth ratio of 0.72 and a beta of 1.35. The company has a quick ratio of 2.24, a current ratio of 2.66 and a debt-to-equity ratio of 0.97. Itron, Inc. has a 12-month low of $77.77 and a 12-month high of $142.00.

Itron (NASDAQ:ITRI) last issued its quarterly earnings results on Tuesday, April 28th. The scientific and technical instruments company reported $1.49 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.26 by $0.23. The business had revenue of $586.98 million for the quarter, compared to the consensus estimate of $572.04 million. Itron had a net margin of 12.31% and a return on equity of 19.54%. The firm’s quarterly revenue was down 3.3% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.52 EPS. Itron has set its Q2 2026 guidance at 1.250-1.350 EPS. On average, research analysts expect that Itron, Inc. will post 6.01 earnings per share for the current fiscal year.

Key Headlines Impacting Itron

Here are the key news stories impacting Itron this week:

• Positive Sentiment: Stephens reiterated an Overweight rating on Itron and kept a $130 price target, signaling substantial upside versus recent trading levels.
• Neutral Sentiment: Several Itron executives sold small amounts of stock, but the filings say the shares were sold mainly to cover tax withholding tied to equity award vesting, which makes the insider activity look routine rather than a major red flag.
• Negative Sentiment: Zacks Research cut multiple future earnings estimates for Itron, including a sharp reduction to Q4 2027 EPS and a lower FY2027 outlook, suggesting softer profit growth ahead.

Wall Street Analyst Weigh In

Several research analysts recently issued reports on the stock. Roth Mkm reiterated a “buy” rating and set a $136.00 price target on shares of Itron in a research report on Wednesday, April 29th. Raymond James Financial assumed coverage on shares of Itron in a research report on Tuesday, April 21st. They set an “underperform” rating on the stock. Robert W. Baird set a $128.00 price target on shares of Itron and gave the stock an “outperform” rating in a research report on Wednesday, February 18th. Needham & Company LLC started coverage on Itron in a report on Friday, March 6th. They set a “buy” rating and a $124.00 price objective for the company. Finally, Oppenheimer raised their target price on shares of Itron from $133.00 to $135.00 and gave the company an “outperform” rating in a research note on Thursday, April 16th. Eight research analysts have rated the stock with a Buy rating, four have given a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $131.22.

Institutional Investors Weigh In On Itron

Institutional investors have recently made changes to their positions in the stock. Private Trust Co. NA grew its stake in shares of Itron by 112.4% during the fourth quarter. Private Trust Co. NA now owns 274 shares of the scientific and technical instruments company’s stock worth $25,000 after purchasing an additional 145 shares during the period. Employees Retirement System of Texas acquired a new stake in shares of Itron during the third quarter worth $32,000. Optiver Holding B.V. acquired a new stake in shares of Itron during the third quarter worth $36,000. Northwestern Mutual Wealth Management Co. grew its stake in shares of Itron by 29.5% during the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 443 shares of the scientific and technical instruments company’s stock worth $41,000 after purchasing an additional 101 shares during the period. Finally, Aster Capital Management DIFC Ltd bought a new stake in shares of Itron in the 3rd quarter valued at about $44,000. 96.19% of the stock is owned by institutional investors and hedge funds.

About Itron

Itron, Inc (NASDAQ: ITRI) is a global technology company that develops innovative solutions to measure, manage and analyze the use of energy and water. Its comprehensive portfolio includes smart meters, data collection devices, communication networks and advanced software applications designed to optimize utility operations and foster sustainable resource management. The company’s offerings enable utilities and cities to accurately monitor consumption patterns, streamline billing processes and improve grid reliability.

Itron’s product lineup spans a range of hardware and software solutions, from residential and commercial smart meters to meter data management systems (MDMS), networked communication platforms and analytics tools.